Boards Overlook CEO Cognitive Capacity as Average Tenure Rises to Nine Years

As corporate boards increasingly favor proven leaders to navigate an era of rapid technological disruption, the average tenure of departing global chief executives has stretched to nine years. In the S&P 500, outgoing chiefs are now serving nearly 12 years before stepping down. This push for stability at the top of the corporate pyramid has introduced a new, largely unspoken risk into modern governance: the cognitive capacity of aging executives.[1][2]

The chief executive role demands relentless performance, constant international travel, and the ability to make high-stakes decisions under extreme pressure. While corporate boards meticulously evaluate a successor's enterprise mindset, stakeholder management skills, and operational credibility, they rarely assess physical and cognitive resilience over a decade-long horizon.[1]

According to the H1 2026 Global CEO Turnover Index published by Russell Reynolds Associates, departing CEOs globally served an average of 9.0 years in the first half of the year, a sharp increase from 6.6 years in early 2025. This marks the second-highest first-half average outgoing tenure in the firm's nine-year tracking period.[2]

The data signals a clear shift in board expectations. Just as elite sports franchises value players who have excelled under the highest pressure, corporate directors are increasingly favoring executives with proven experience leading at the top. In the first half of 2026, 23 percent of incoming CEOs globally had previously led a public company.[1][2]

However, this preference for seasoned judgment means that a board may appoint a leader based on decades of accumulated operating experience, and then expect them to perform at an elite level for much of another decade. This reality is prompting governance experts to warn that succession planning is only as strong as the executive's biological capacity to sustain the role.[1]

Academic research highlights a complex picture of aging and executive function. Studies on cognitive decline in leadership note that age-related changes can subtly impair memory, processing speed, and fluid intelligence—the very traits required to quickly process novel threats and adapt to rapid industry disruptions.[3]

When a chief executive's cognitive agility falters, the effects ripple across the entire institution. Strategic decision-making slows, resource management can become inefficient, and the organization may miss critical windows for investment or adaptation.[3]

Furthermore, cognitive impairment at the top can severely impact organizational culture. Employees may lose morale as trust in leadership wanes, leading to lower motivation and productivity. Ultimately, shareholder confidence can be shaken if investors perceive that the company's strategic direction is being compromised by a leader's declining acuity.[3]

Yet, cognitive aging is not uniformly detrimental, and age alone is a poor predictor of decision-making capacity. Research from the UT Dallas Center for BrainHealth demonstrates that while fluid intelligence may decrease, "strategic learning"—the ability to sift crucial information from the trivial—can actually increase with age in normally functioning adults.[4]

The UT Dallas study, which investigated the connection between cognitive health and decision-making in adults across their 50s, 60s, and 70s, found that the oldest participant group slightly surpassed the rest in strategic learning capacity. These older decision-makers often exhibited higher levels of conscientiousness and were less prone to hyper-vigilant, impulsive choices.[4]

This nuance suggests that an aging chief executive might process novel technological threats more slowly than a younger counterpart, but evaluate long-term strategic acquisitions with superior judgment. The extensive life experience, reasoning ability, and accumulated knowledge of older leaders can preserve or even enhance their decision-making capabilities, provided there is no underlying medical condition.[4]

Despite these realities, corporate boards remain largely unprepared to manage the intersection of aging and executive performance. Succession planning frameworks rarely include ongoing executive health assessments or protocols for addressing subtle cognitive impairment without triggering a public crisis.[1][3]

Governance scholars argue that the current approach leaves organizations dangerously exposed. They advocate for a structural overhaul in how boards monitor leadership health, proposing that regular executive health assessments and board-level training on recognizing the early signs of cognitive decline should become standard practice.[3][5]

Implementing these measures requires balancing the fiduciary duty to protect the organization with the ethical imperative to respect the dignity of the affected executive. Creating structured, dignified off-ramps for aging leaders ensures that their contributions are honored while safeguarding the company's future.[3][5]

Ultimately, the lengthening tenure of chief executives means that corporate stability is increasingly tied to the biological resilience of a single individual. As boards continue to place a premium on proven experience, they are being urged to expand their definition of leadership readiness to include ongoing cognitive health evaluations, ensuring that the executives tasked with decade-long mandates can sustain elite performance from day one to year ten.[1][5]